ProfileGDS4718 / 213015_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 73% 82% 96% 74% 79% 86% 83% 80% 80% 70% 73% 81% 79% 83% 83% 82% 79% 84% 88% 90% 76% 80% 77% 75% 76% 84% 77% 89% 79% 82% 89% 89% 79% 76% 86% 84% 80% 82% 82% 94% 81% 84% 85% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.1734873
GSM549102patient 115, normal, homogenized [OPG study]8.0051282
GSM549104patient 119, normal, homogenized [OPG study]10.647896
GSM549108patient 138, normal, homogenized [OPG study]7.2016474
GSM549119patient 077, normal, homogenized [OPG study]7.7019279
GSM549133patient 032, cancer, homogenized [OPG study]8.683886
GSM549139patient 042, cancer, homogenized [OPG study]8.2980183
GSM549099patient 107, normal, homogenized [OPG study]7.7939480
GSM549109patient 139, normal, homogenized [OPG study]7.7781580
GSM549110patient 046, normal, homogenized [OPG study]6.872370
GSM549114patient 063, normal, homogenized [OPG study]7.1327873
GSM549122patient 082, normal, homogenized [OPG study]8.0180481
GSM549134patient 033, cancer, homogenized [OPG study]7.7975479
GSM549136patient 036, cancer, homogenized [OPG study]8.2806283
GSM549140patient 044, cancer, homogenized [OPG study]8.3119383
GSM549111patient 047, normal, homogenized [OPG study]8.202782
GSM549113patient 057, normal, homogenized [OPG study]7.7870579
GSM549132patient 031, cancer, homogenized [OPG study]8.2989584
GSM549137patient 038, cancer, homogenized [OPG study]8.8476588
GSM549142patient 047, cancer, homogenized [OPG study]8.7585490
GSM549100patient 110, normal, homogenized [OPG study]7.4046276
GSM549107patient 135, normal, homogenized [OPG study]7.9150380
GSM549115patient 068, normal, homogenized [OPG study]7.6309977
GSM549116patient 072, normal, homogenized [OPG study]7.3354575
GSM549120patient 078, normal, homogenized [OPG study]7.4502676
GSM549131patient 030, cancer, homogenized [OPG study]8.3929384
GSM549118patient 074, normal, homogenized [OPG study]7.5916177
GSM549129patient 027, cancer, homogenized [OPG study]8.8890789
GSM549123patient 088, normal, homogenized [OPG study]7.7354179
GSM549124patient 006, cancer, homogenized [OPG study]8.0136382
GSM549126patient 015, cancer, homogenized [OPG study]8.9121389
GSM549128patient 025, cancer, homogenized [OPG study]8.9880789
GSM549103patient 117, normal, homogenized [OPG study]7.5796879
GSM549117patient 073, normal, homogenized [OPG study]7.3764876
GSM549138patient 041, cancer, homogenized [OPG study]8.5813286
GSM549141patient 045, cancer, homogenized [OPG study]8.5034584
GSM549130patient 028, cancer, homogenized [OPG study]7.8831980
GSM549101patient 111, normal, homogenized [OPG study]8.0190982
GSM549105patient 128, normal, homogenized [OPG study]8.0697982
GSM549106patient 134, normal, homogenized [OPG study]10.110494
GSM549112patient 048, normal, homogenized [OPG study]7.9500481
GSM549125patient 011, cancer, homogenized [OPG study]8.2346584
GSM549127patient 024, cancer, homogenized [OPG study]8.4680585
GSM549135patient 035, cancer, homogenized [OPG study]9.5110491